BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27713321)

  • 1. Beyond Genetics-Stratified and Personalised Medicines Using Multiple Parameters.
    Peck R; Smith P
    Pharmaceuticals (Basel); 2010 May; 3(5):1637-1651. PubMed ID: 27713321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and personalised medicine.
    Kalow W
    Fundam Clin Pharmacol; 2002 Oct; 16(5):337-42. PubMed ID: 12602458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored medicine: whom will it fit? The ethics of patient and disease stratification.
    Smart A; Martin P; Parker M
    Bioethics; 2004 Aug; 18(4):322-42. PubMed ID: 15449405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine].
    Müller-Berghaus J; Volkers P; Scherer J; Cichutek K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1538-44. PubMed ID: 24170083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacogenetics of antiretroviral therapy.
    Phillips EJ
    Curr Opin HIV AIDS; 2006 May; 1(3):249-56. PubMed ID: 19372817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenetics--implications for health management and health care economics].
    Weihrauch TR
    Med Klin (Munich); 2002 Jul; 97(7):420-8. PubMed ID: 12168482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential genetic causes of heterogeneity of treatment effects.
    Goldstein DB; Need AC; Singh R; Sisodiya SM
    Am J Med; 2007 Apr; 120(4 Suppl 1):S21-5. PubMed ID: 17403378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetics in primary health care: implementation and future expectations].
    Houwink EJ; Rigter T; Swen JJ; Cornel MC; Kienhuis A; Rodenburg W; Weda M
    Ned Tijdschr Geneeskd; 2015; 159():A9204. PubMed ID: 26507063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics/genomics and drug effects.
    Heller F
    Acta Clin Belg; 2013; 68(2):77-80. PubMed ID: 23967712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of drug efficacy: opportunities and challenges.
    Nelson MR; Johnson T; Warren L; Hughes AR; Chissoe SL; Xu CF; Waterworth DM
    Nat Rev Genet; 2016 Apr; 17(4):197-206. PubMed ID: 26972588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Primer to Pharmacogenetics of Postoperative Pain Management.
    Aroke EN; Kittelsrud JM
    AANA J; 2019 Apr; 87(2):131-137. PubMed ID: 31587726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".
    Desiere F; Romano Spica V
    N Biotechnol; 2012 Sep; 29(6):611-2. PubMed ID: 22504736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.